Erratum
Background
Interim analysis
First results INTEGRATE
Risk estimation
Amendment in protocol
-
a family history of cardiovascular disease
-
BMI >27
-
smokers aged 50 and older
Consequences
-
The aim of the study remains unchanged: “the effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care”.
-
The sample size calculation is no longer applicable. The intervention group will be smaller than expected in the original protocol. This has consequences for the power of the study. The study might not have sufficient power to detect a difference in the number of smokers. However, the study will have sufficient power to detect differences in the other CMD risk factors such as BMI and blood pressure.
-
The cost-effectiveness analysis will be performed according to plan
-
Additional measurements will be performed in the last two groups of study participants in April and June 2016 (eligible participants n = 10.000) with risk scores below threshold and aforementioned risk factors for CMD.